Xylo Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Xylo Technologies wird voraussichtlich ein Umsatzwachstum verzeichnen at 34.4% per annum.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	17.1%
Wachstumsrate der Einnahmen	34.4%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	22 Jul 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

We Believe Medigus' (NASDAQ:MDGS) Earnings Are A Poor Guide For Its Profitability

Sep 28

Medigus jumps 4% as subsidiary Charging Robotics assigns first distributor for its wireless EV robotic charging pad

Jun 17

Medigus launches ADS offering

Jan 11

Medigus expands EV operations with acquisition of autonomous technology, shares up 31%

Jan 08

New finance cheif at Medigus

Dec 01

Medigus shares +42% on plans to enter micro-mobility EV market

Nov 19

Medigus under pressure after increasing stake to ~33% in Polyrizon

Nov 09

Gewinn- und Umsatzwachstumsprognosen

NasdaqCM:XYLO - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2025	111	N/A	N/A	N/A	1
12/31/2024	105	N/A	N/A	N/A	1
6/30/2024	58	-16	-4	-4	N/A
3/31/2024	75	-16	-6	-5	N/A
12/31/2023	92	-16	-8	-6	N/A
9/30/2023	101	-15	-8	-6	N/A
6/30/2023	110	-14	-8	-6	N/A
3/31/2023	101	-12	-7	-6	N/A
12/31/2022	92	-10	-6	-6	N/A
9/30/2022	67	-8	-5	-5	N/A
6/30/2022	43	-7	-5	-5	N/A
3/31/2022	26	0	-8	-5	N/A
12/31/2021	10	7	-10	-5	N/A
9/30/2021	6	7	-10	-5	N/A
6/30/2021	3	8	-10	-5	N/A
3/31/2021	2	2	-8	-6	N/A
12/31/2020	1	-4	-6	-6	N/A
9/30/2020	0	-10	-5	-5	N/A
6/30/2020	0	-15	-4	-4	N/A
3/31/2020	0	-15	-3	-3	N/A
12/31/2019	0	-14	-3	-3	N/A
9/30/2019	0	-9	-4	-4	N/A
6/30/2019	0	-6	-4	-4	N/A
3/31/2019	0	-6	-4	-4	N/A
12/31/2018	0	-7	-4	-4	N/A
9/30/2018	0	-6	-4	-4	N/A
6/30/2018	0	-4	-4	-4	N/A
3/31/2018	0	-2	N/A	-5	N/A
12/31/2017	0	-3	N/A	-5	N/A
9/30/2017	0	-4	N/A	-5	N/A
6/30/2017	0	-5	N/A	-6	N/A
3/31/2017	0	-8	N/A	-7	N/A
12/31/2016	1	-9	N/A	-9	N/A
9/30/2016	1	-10	N/A	-11	N/A
6/30/2016	1	-10	N/A	-11	N/A
3/31/2016	1	-10	N/A	-10	N/A
12/31/2015	1	-10	N/A	-7	N/A
9/30/2015	1	-8	N/A	-6	N/A
6/30/2015	0	-7	N/A	-6	N/A
3/31/2015	0	-6	N/A	-5	N/A
12/31/2014	1	-6	N/A	-8	N/A
9/30/2014	1	-5	N/A	-7	N/A
6/30/2014	1	-5	N/A	-6	N/A
3/31/2014	1	-2	N/A	-1	N/A
12/31/2013	1	-1	N/A	-7	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von XYLO über der Sparquote liegt (2.6%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von XYLO schneller wachsen werden als der Markt US

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von XYLO in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: XYLODie Einnahmen des Unternehmens (34.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: XYLODie Einnahmen des Unternehmens (34.4% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von XYLO in 3 Jahren voraussichtlich hoch sein wird

Xylo Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target decreased to US$67.50

Consensus forecasts updated

Recent updates

First half 2024 earnings released: US$11.33 loss per share (vs US$13.39 loss in 1H 2023)

Full year 2023 earnings released: US$9.50 loss per share (vs US$6.04 loss in FY 2022)

Medigus Ltd.(NasdaqCM:MDGS) dropped from NASDAQ Composite Index

New minor risk - Financial data availability

Medigus Ltd. Announces Launch of Unique Pilot of A Wireless Charging Solution

New minor risk - Share price stability

New minor risk - Shareholder dilution

Medigus Ltd., Annual General Meeting, Aug 07, 2023

existing shareholders and office holders in ScoutCam acquired 46.11% stake in ScoutCam Inc. (OTCPK:SCTC) from Medigus Ltd. (NasdaqCM:MDGS) for $6 million.

M. Arkin (1999) Ltd. acquired 46.11% stake in ScoutCam Inc. (OTCPK:SCTC) from Medigus Ltd. (NasdaqCM:MDGS) for $6 million.

Full year 2022 earnings released: US$6.04 loss per share (vs US$4.42 profit in FY 2021)

Medigus Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Price target decreased to US$67.50

Medigus says ScoutCam appoints Yehu Ofer as CEO

Consensus forecasts updated

First half 2022 earnings released: US$0.15 loss per share (vs US$0.44 profit in 1H 2021)

Medigus reports 1H results

What Does Medigus Ltd.'s (NASDAQ:MDGS) Share Price Indicate?

Medigus board files a motion to approve an up to $1.6M dividend distribution

Medigus Announces Receipt of Nasdaq Notice of Bid Price Deficiency

Medigus Ltd., Annual General Meeting, Jun 16, 2022

Is Now An Opportune Moment To Examine Medigus Ltd. (NASDAQ:MDGS)?

Full year 2021 earnings released: EPS: US$0.20 (vs US$0.65 loss in FY 2020)

Medigus Ltd. (NasdaqCM:MDGS) acquired a 35.1% stake in Fuel Doctor Holdings, Inc. (OTCPK:FDOC) for $0.26 million.

Medigus Ltd. Micro Mobility Vehicle JV, Revoltz, Launches Pilot Program At A New Autonomous Supermarket

A consortium of investors led by Medigus Ltd. (NasdaqCM:MDGS), L.I.A. Pure Capital Ltd. along with other buyers including a group of individuals completed the acquisition of ParaZero Technologies Ltd from Delta Drone International Limited (ASX:DLT).

Medigus Ltd. Announces First Authorization for Commercial Drone Deliveries in Brazil

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

High number of new directors

We Believe Medigus' (NASDAQ:MDGS) Earnings Are A Poor Guide For Its Profitability

First half 2021 earnings released: EPS US$0.44 (vs US$0.56 loss in 1H 2020)

Medigus Joint Venture, Revoltz Completes First Micromobility Vehicle Functional Prototype

Medigus jumps 4% as subsidiary Charging Robotics assigns first distributor for its wireless EV robotic charging pad

Medigus Ltd. announced delayed 20-F filing

Medigus Forms Joint Venture for the Development of Urban and Logistics Electric Vehicles with Emuze Founders

Medigus Ltd. Initiates Development of Robotic Wireless Charging Pad for Electric Vehicles

New 90-day high: US$3.69

Medigus launches ADS offering

Medigus Ltd. Enters the Wireless Charging Market for Electric Vehicle with New Autonomous Technology

Medigus expands EV operations with acquisition of autonomous technology, shares up 31%

Medigus Ltd. (TASE:MDGS) completed the acquisition of 50.01% stake in Purex Incorporated and Smart Repair Pro, Inc.

New finance cheif at Medigus

Tatiana Yosef to Step Down as Chief Financial Officer of Medigus Ltd., with Effect from January 15, 2021

Medigus Signs MOU to Enter Electric Vehicles and Electric Charging Market

Medigus shares +42% on plans to enter micro-mobility EV market

Medigus under pressure after increasing stake to ~33% in Polyrizon

Medigus Ltd. (TASE:MDGS) signed a share purchase agreement to acquire an unknown stake in Eventer Technologies Ltd.

Medigus Ltd. (TASE:MDGS) agreed to acquire additional 15.1% stake in Gix Internet Ltd (TASE:GIX).

Medigus Ltd. (TASE:MDGS) signed a non-binding letter of intent to acquire a controlling interest of 50.1% in Purex Incorporated and Smart Repair Pro, Inc. for $2.5 million.

Medigus Ltd. (TASE:MDGS) completed the acquisition of Linkury LTD. from Algomizer Ltd (TASE:ALMO).

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken